Homopterocarpanes as bridged triarylethylene analogues: Synthesis and antagonistic effects in human MCF-7 breast cancer cells

Farmaco

Volumn 60, Issue 2, 2005, Pages 135-147

  Rampa, Angela ^a   Bisi, Alessandra ^a   Belluti, Federica ^a   Gobbi, Silvia ^a   Piazzi, Lorna ^a   Valenti, Piero ^a   Zampiron, Antonella ^b   Caputo, Anna ^b   Varani, Katia ^c   Borea, Pier Andrea ^c   Carrara, Maria ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Homopterocarpanes; MCF 7 breast cancer cells; Synthesis

Indexed keywords

1 (2 HYDROXY 4 METHOXYPHENYL) 3 [4 (2 TETRAHYDRO 1H 1 PYRROLYLETHOXY) PHENYL] 2 PROPEN 1 ONE; 1 [2 HYDROXY 4 (2 MORPHOLINOETHOXY)PHENYL] 1 ETHANONE; 1 [2 HYDROXY 4 (2 MORPHOLINOETHOXY)PHENYL] 3 (4 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 [2 HYDROXY 4 (2 PIPERIDINOETHOXY)PHENYL] 1 ETHANONE; 1 [2 HYDROXY 4 (2 PIPERIDINOETHOXY)PHENYL] 3 (4 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 [2 HYDROXY 4 (2 TETRAHYDRO 1H 1 PYRROLYLETHOXY)PHENYL] 1 ETHANONE; 1 [2 HYDROXY 4 (2 TETRAHYDRO 1H PYRROLYLETHOXY)PHENYL] 3 (4 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 [2 HYDROXY 4 (3 TETRAHYDRO 1H 1 PYRROLYLPROPOXY)PHENYL] 1 ETHANONE; 1 [2 HYDROXY 4 (3 TETRAHYDRO 1H PYRROLYLPROPOXY)PHENYL] 3 (4 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 [2 HYDROXY 4 (4 TETRAHYDRO 1H 1 PYRROLYBUTOXY)PHENYL] 1 ETHANONE; 1 [2 HYDROXY 4 (4 TETRAHYDRO 1H PYRROLYLBUTOXY)PHENYL] 3 (4 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 [2 HYDROXY 4 (5 TETRAHYDRO 1H 1 PYRROLYLPENTYLOXY)PHENYL] 1 ETHANONE; 1 [2 HYDROXY 4 [(5 TETRAHYDRO 1H 1 PYRROLYLPENTYL)OXY]PHENYL] 3 (4 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 [2 HYDROXY 4 [2 (4 PHENYLPIPERAZINO)ETHOXY]PHENYL] 3 (4 METHOXYPHENYL) 2 PROPEN 1 ONE; 1 [2 HYDROXY 4 [2 (PHENYLPIPERAZINO)ETHOXY]PHENYL] 1 ETHANONE; 2 (4 METHOXYPHENYL) 7 (2 MORPHOLINOETHOXY) 4 CHROMANONE; 2 (4 METHOXYPHENYL) 7 (2 PIPERIDINOETHOXY) 4 CHROMANONE; 2 (4 METHOXYPHENYL) 7 (2 TETRAHYDRO 1H 1 PYRROLYLETHOXY) 4 CHROMANONE; 2 (4 METHOXYPHENYL) 7 (3 TETRAHYDRO 1H 1 PYRROLYLPROPOXY) 4 CHROMANONE; 2 (4 METHOXYPHENYL) 7 (4 TETRAHYDRO 1H 1 PYRROLYLBUTOXY) 4 CHROMANONE; 2 (4 METHOXYPHENYL) 7 [(5 TETRAHYDRO 1H 1 PYRROLYLPENTYL)OXY] 4 CHROMANONE; 3 (2 HYDROXY 5 METHOXYBENZYL) 2 (4 METHOXYPHENYL) 4 CHROMANONE; 3 (2 HYDROXY 5 METHOXYBENZYL) 7 METHOXY 2 (4 METHOXYPHENYL) 4 CHROMANONE; 3 [1 [2 (BENZYLOXY) 5 METHOXYPHENYL]METHYLIDENE] 2 (4 METHOXYPHENYL) 4 CHROMANONE; 3 [1 [2 (BENZYLOXY) 5 METHOXYPHENYL]METHYLIDENE] 7 METHOXY 2 (4 METHOXYPHENYL) 4 CHROMANONE; 4 (2 TETRAHYDRO 1H 1 PYRROLYLETHOXY)BENZALDEHYDE; 4 CHROMANONE DERIVATIVE; 7 METHOXY 2 [4 (2 TETRAHYDRO 1H 1 PYRROLYLETHOXY)PHENYL] 4 CHROMANONE; BENZALDEHYDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL;

EID: 20044390918     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2004.09.006     Document Type: Article

References (35)

1. L.J. Lerner, and V.C. Jordan Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture Cancer Res. 50 1990 4177 4189
2. E.M. Bickoff, A.N. Booth, R.L. Lyman, A.L. Livingston, C.R. Thompson, and G.O. Kohler Isolation of a new estrogen from Ladino Clover Agric. Food Chem. 6 1958 536 539
3. J.F. Miquel, and J. Gilbert A chemical classification of nonsteroidal antagonists of sex-steroid hormone action J. Steroid Biochem. 31 1988 525 544
4. P. Neven, and H. Vernaeve Guidelines for monitoring patients taking tamoxifen treatment Drug Saf 22 2000 1 11
5. E. Coezy, J.L. Borgna, and H. Rocherfort Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth Cancer Res. 42 1982 317 323
6. W.T. Couldwell, M.H. Weiss, C.M. Degiorgio, L.P. Weimar, D.R. Hinton, and G.R. Ehresmsan Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen Neurosurgery 32 1993 485 489
7. J.D. Croxtall, C. Emmas, J.O. White, Q. Choudhary, and R.J. Flower Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells Biochem. Pharmacol. 47 1994 197 202
8. C. Charlier, A. Chariot, N. Antoine, M. Merville, J. Gielen, and V. Castronovo Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells Biochem. Pharmacol. 49 1995 351 358
9. N. Altan, Y. Chen, M. Schindler, and S.M. Simon Tamoxifen inhibits acidification in cells independent of the estrogen receptor Proc. Natl. Acad. Sci. USA 96 1999 4432 4437
10. Y. Chen, M. Schindler, and S.M. Simon A Mechanism for Tamoxifen-mediated inhibition of acidification J. Biol. Chem. 274 1999 18364 18373
11. P. Da Re, P. Valenti, L. Cateni, and P.L. Barili Synthesis of (±) cis 6a,12a-dihydro-6H,7H- [1]-benzopyrano-[4,3-b]- [1]-benzopyran Tetrahedron Lett. 17 1976 71 72
12. P. Valenti, P. Montanari, P.L. Barili, and P. Da Re Über homopterocarpan Arch. Pharm. (Weinheim) 313 1980 289
13. P. Valenti, G. Fabbri, A. Rampa, A. Bisi, and F. Velluti Synthesis of a series of homopterocarpane derivatives with potential antitumor and anti-AIDS activity Farmaco 52 1997 13 19
14. G.M. Amstead, S.R. Wilson, and J.A. Katzenellenbogen 2-Arylindenes and 2-arylindenones: molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor J. Med. Chem. 32 1989 2163 2171
15. A. Saeed, A.P. Sharma, N. Durani, R. Jain, S. Durani, and R.S. Kapil Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans J. Med. Chem. 33 1990 3210 3216
16. T. Polossek, R. Ambros, S. Von Angerer, G. Brandl, A. Mannschreck, and E. Von Angerer 6-Alkyl-12-formylindolo[2,1-a]isoquinolines. Syntheses, estrogen receptor binding affinities, and stereospecific cytostatic activity J. Med. Chem. 35 1992 3537 3547
17. S. Ray, A. Tandon, I. Dwivedy, S.R. Wilson, J.P. O'Neil, and J.A. Katzenellenbogen An X-ray crystallographic study of the nonsteroidal contraceptive agent centchroman J. Med. Chem. 37 1994 696 700
18. T.A. Grese, L.D. Pennington, J.P. Sluka, M.D. Adrian, W.C. Harlan, and T.R. Fuson Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators J. Med. Chem. 41 1998 1272 1283
19. Y. Jacquot, L. Bermont, H. Giorgi, B. Refouvelet, G.L. Adessi, E. Daubrosse, and A. Xicluna Substituted benzopyranobenzothiazinones. Synthesis and estrogenic activity on MCF-7 breast carcinoma cells Eur. J. Med. Chem. 36 2001 127 136
20. J. Adrieux, J. Aknin, B. Bodo, C. Deschamps-Vallet, M. Meyer-Dayan, and D. Molho Ŕactivit́ des perchlorates de flavylium vis-̀-vis des agents nucl̀ophiles. I. R̀duction par les ions hydrures Bull. Soc. Chim. Fr. 11 1976 1967 1974 -12
21. K. Juppen, and S. Kostanecki Über das 3,4′-dioxyflavonol Chem. Ber. 37 1904 4161 4163
22. N. Vinot, and P. Maitte Synth̀se de dimethyl-2,2 chromannediones-3,4: condensation avec les ortho-diaminopyridines J. Heterocycl. Chem. 26 1989 1013 1021
23. R.A. Magarian, K.S. Avor, L.B. Overacre, J. Kunchandy, and T.R. Paxton Synthesis and biological evaluation of basic side chain derivatives of analog II as pure antiestrogens and antitumor agents Anticancer Drug Des. 10 1995 311 331
24. M.J. Meegan, R.B. Hughes, D. Lloyd, D.C. Williams, and D.M. Zisterer Flexible estrogen receptor modulators: design, synthesis, and antagonistic effects in human MCF-7 breast cancer cells J. Med. Chem. 44 2001 1072 1084
25. A. Howell, C.K. Osborne, C. Morris, and A.E. Wakeling ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen Cancer 89 2000 817 825
26. A. Howell, D.J. Dodwell, H. Anderson, and J. Redford Response after withdrawal of tamoxifen and progestogens in advanced breast cancer Ann. Oncol. 3 1992 611 617
27. M.M. Gotterdis, and V.C. Jordan Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration Cancer Res. 48 1988 5183 5187
28. C.K. Osborn, E.B. Coronado-Heinsohon, S.G. Hilsenbeck, B.L. McCues, A.E. Wakeling, and R.A. McClelland Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer J. Natl. Cancer Inst. 87 1995 746 750
29. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
30. M. Carrara, S. D'Ancona, and L. Cima An inert mixture for solubilizing lipophilic drugs in cell culture assays Arch. Toxicol. 11 Suppl. 1987 338 343
31. R.J. Tallarida, and R.B. Murray Manual of Pharmacological Calculations with Computer Programs 1987 Springer-Verlag Berlin 8 153
32. G. Paganetto, F. Campi, K. Varani, A. Piffanelli, G. Giovannini, and P.A. Borea Endocrine-disrupting agents on healthy human tissues Pharmacol. Toxicol. 86 2000 24 29
33. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
34. 50) of an enzymatic reaction Biochem. Pharmacol. 22 1973 3099 3108
35. P.J. Munson, and D. Rodbard Ligand: a versatile computerized approach for characterization of ligand-binding systems Anal. Biochem. 107 1980 220 239